Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Inmed Pharmaceuticals Inc (NQ: INM ) 0.2630 +0.0095 (+3.75%) Streaming Delayed Price Updated: 3:59 PM EDT, Jul 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Inmed Pharmaceuticals Inc < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding November 22, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Close on $6M Private Placement Funding November 22, 2022 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property InMed Pharmaceuticals Announces Closing of $6 Million Private Placement Priced at a Premium to Market November 21, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Why InMed Pharmaceuticals Shares Tumbled 28%; Here Are 67 Biggest Movers From Friday November 21, 2022 Gainers AGBA Group Holding Limited (NASDAQ: AGBA) gained 50.7% to close at $6.78 on Friday. Via Benzinga CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding November 18, 2022 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Why PaxMedica Shares Are Trading Higher By Over 53%? Here Are 47 Stocks Moving In Friday's Mid-Day Session November 18, 2022 Gainers PaxMedica, Inc. (NASDAQ: PXMD) gained 53.5% to $2.38 after the company announced an equity investment agreement for up to $20 million with Lincoln Park Capital. Via Benzinga CannabisNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Anticipated $6M Private Placement Funding November 18, 2022 Via CannabisNewsWire Topics Intellectual Property Exposures Intellectual Property InMed Pharmaceuticals Announces $6 Million Private Placement Priced at a Premium to Market November 18, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Accounting VP, Controller November 17, 2022 Via Investor Brand Network InMed Provides Update on Management Changes November 17, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Why Foresight Autonomous Shares Jumped 33%; Here Are 83 Biggest Movers From Yesterday November 17, 2022 Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares surged 106.3% to close at $0.21 on Wednesday after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. Via Benzinga InMed Pharmaceuticals (NASDAQ: INM) Says Research Grant to Test Cannabinoid Analogs as a Potential Treatment for Alzheimer’s, Parkinson’s and Huntington’s Disease November 16, 2022 InMed Pharmaceuticals, Inc. (NASDAQ: INM) is a pharmaceutical research and development company that is focused on utilizing cannabinoids and related Via Spotlight Growth S&P 500 Down 0.8%; Lowe's Earnings Top Expectations November 16, 2022 U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 1.5% on Wednesday. Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Gains Alliance Grant Funding, Launches New Program with UBC Professor November 16, 2022 Via Investor Brand Network Why Target Shares Are Trading Lower By 14%? Here Are 56 Stocks Moving In Wednesday's Mid-Day Session November 16, 2022 Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 109% to $0.2115 after dipping around 48% on Tuesday. Fast Radius established a timeline for a Chapter 11 sale process. Via Benzinga Dow Edges Higher; Crude Oil Drops Sharply November 16, 2022 U.S. stocks traded mixed midway through trading, with the Dow Jones turning higher on Wednesday. Via Benzinga Nasdaq Drops Over 100 Points; US Retail Sales Rise 1.3% November 16, 2022 U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping more than 100 points on Wednesday. Via Benzinga InMed Pharmaceuticals Advances Neurodegenerative Disease Program with Natural Sciences and Engineering Research Council of Canada ("NSERC") Alliance Grant Funding November 16, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday November 15, 2022 We're starting off the day with a look at the biggest pre-market stock movers that traders will want to know about for Tuesday morning! Via InvestorPlace Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday's Mid-Day Session November 15, 2022 Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split. Via Benzinga TinyGemsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Q1 2023 Financial Report, Corporate Update November 14, 2022 Via Investor Brand Network Tyson Foods, AECOM And 3 Stocks To Watch Heading Into Monday November 14, 2022 With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: Via Benzinga InMed Pharmaceuticals Reports First Quarter Fiscal 2023 Financial Results and Provides Business Update November 11, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event November 10, 2022 Via Investor Brand Network Registration Now Open For Tribe Public’s Webinar Event "Exploring the Neuroprotective Qualities of Rare Cannabinoids" Featuring InMed’s Management Team On November 17, 2022 November 10, 2022 Meet with InMed’s President and CEO Eric A. Adams and Eric Hsu, SVP of Preclinical Research and Development From InMed Pharmaceuticals Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Monday October 31, 2022 During Monday's session, 96 stocks hit new 52-week lows. Via Benzinga BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Announces Support of EB Awareness Week October 26, 2022 Via Investor Brand Network Stocks That Hit 52-Week Lows On Thursday October 27, 2022 On Thursday, 111 stocks hit new 52-week lows. Via Benzinga InMed Pharmaceuticals Supports Epidermolysis Bullosa Awareness Week October 26, 2022 From InMed Pharmaceuticals Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Tuesday October 25, 2022 On Tuesday, 120 companies set new 52-week lows. Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 13 14 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.